Cryonics Revival Scenarios & Potential Roadmaps & Hypotheses

Published November 1, 2026.

A study published in npj Biosensing on October 31 investigates whether palladium electrodes can reset biological binding interfaces by changing local acidity electrically, without adding regeneration reagents.

Sharkey and colleagues tested an integrated microfluidic platform. Electrode surface area mainly affected how quickly pH changed, while stronger buffering and restricted transport reduced the magnitude and spread of those changes.

The approach released IgG2 antibodies from immobilized peptide receptors over three binding–regeneration cycles. However, compatibility depended on the interface: electrically driven acidification degraded signals from methylene-blue-labeled aptamer electrodes, including loss of a distinguishable redox peak. Alkalinization qualitatively reproduced their expected pH-dependent response.

The result is a laboratory demonstration with useful design constraints, rather than proof of a universally reusable biosensor. Three cycles do not establish long-term durability, and the work does not demonstrate clinical diagnostic performance. Some authors disclose financial interests in Chromagenix or DermiSense. The peer-reviewed accepted article remains subject to editorial changes.

Source: Sharkey et al., npj Biosensing, October 31, 2026.